The global scleral lens market size was valued at USD 327.04 billion in 2024 and is expected to attain around USD 982.68 billion by 2034, growing at a CAGR of 11.63%.

Get a Free Sample Copy of the Report@ https://www.precedenceresearch.com/sample/5807

Scleral Lens Market Key Points

• In 2024, North America accounted for the highest market share at 41%.

• Asia Pacific is poised to register the highest CAGR during the forecast timeline.

• The dominant product types were corneo-scleral and semi-scleral lenses.

• Mini-scleral lenses are forecasted to grow at an accelerated rate.

• The irregular cornea segment was the leading application area.

• The ocular surface disease segment is expected to gain traction quickly.

• Eye clinics emerged as the top end-user segment in 2024.

• Hospitals are anticipated to experience the strongest growth ahead.

Smart Vision: How AI is Reshaping the Scleral Lens Market

AI-Enhanced Customization and Fitting:
Artificial Intelligence is significantly transforming the scleral lens market by improving precision in lens customization and patient fitting. AI-powered diagnostic tools, combined with corneal topography and ocular surface data, allow practitioners to design highly personalized scleral lenses that offer better comfort and visual outcomes. This advanced approach reduces fitting time, minimizes trial-and-error processes, and enhances overall patient satisfaction—especially for those with irregular corneas or complex ocular conditions.

Predictive Analytics and Operational Efficiency:
AI is also playing a key role in predicting patient outcomes, managing inventory, and automating back-end manufacturing processes. Through machine learning algorithms, manufacturers can analyze vast datasets to forecast demand trends and identify patterns in lens usage and performance. This enables more efficient production planning, reduced material waste, and quicker turnaround times. As a result, clinics and optical retailers benefit from improved operational workflows and enhanced service delivery.

Market Overview

Scleral lenses are becoming a vital tool in managing complex eye conditions that cannot be effectively corrected with glasses or standard contact lenses. They provide a therapeutic benefit by creating a tear-filled vault over the cornea, making them suitable for patients with dry eyes, irregular corneas, and post-surgical complications.

Market Scope

Market Dynamics

Market Drivers

The market is driven by increasing demand for advanced optical solutions, improved access to specialty eye care, and the rising geriatric population. A surge in eye conditions related to digital eye strain and environmental factors also contributes to the demand.

Market Opportunities

With technological innovations such as AI-assisted lens design and 3D printing, manufacturers have the chance to deliver more accurate, comfortable, and affordable solutions. Educational initiatives aimed at practitioners and patients also create new growth avenues.

Market Challenges

High production costs, limited insurance coverage, and the complexity of fittings can reduce accessibility. In addition, practitioner training remains a significant challenge in rural or less-developed regions.

Regional Insights

North America continues to dominate due to strong clinical research, availability of specialty lens providers, and increasing patient awareness. Meanwhile, Asia Pacific is projected to grow rapidly due to expanding healthcare infrastructure and a growing middle-class population with improved spending capacity.

Scleral Lens Market Companies

• ABB Optical Group
• Alden Optical Laboratories
• Art Optical Contact Lens Inc.
• Bausch Health Companies Inc.
• Blanchard Lab
• Boston Sight
• Essilor
• SynergEyes
• TruForm Optics Inc.
• Valley Contax
• Visionary Optics

Latest Announcements by Market Leaders

• In February 2025, ABB Optical Group announced the launch of the Delta Scleral, the next generation of scleral contact lenses, which premiered at GSLS 2025. ABB also announced the launch of HydroPure MPS and HydroPure Lubricating Eye Drops for both soft and gas-permeable lenses. HydroPure is an exclusive product line for ECPs through ABB Optical Group.
• In February 2023, Visionary Optics announced the launch of  Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting; according to the release, the lens design was based on clinical experience and analysis of data from more than 10,000 fittings.

Recent Developments

• In May 2024, Bausch + Lomb Corporation announced the U.S. launch of Zenlens ECHO, a non-prosthetic, custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes, including patients who have advanced ocular conditions such as corneal degeneration and certain postoperative conditions.
• In February 2023, Visionary Optics launched Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting. The lens design was based on clinical experience and analysis of data from more than 10,000 fittings.

Segments Covered in the Report

By Type

• Corneo-Scleral Lenses and Semi-Scleral Lenses
• Mini-Scleral Lenses
• Full Scleral Lenses

By Application

• Irregular Cornea
• Ocular Surface Disease
• Refractive Error
• Other Applications

By End-User

• Hospitals
• Eye Clinics
• Other End Users

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Also Read: Water for Injection Market 

Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/